These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 23081745

  • 21. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ, Boorsma M, Bergqvist PB, Winter TH, Aalbers R.
    Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial.
    Bodzenta-Lukaszyk A, van Noord J, Schröder-Babo W, McAulay K, McIver T.
    Curr Med Res Opin; 2013 May; 29(5):579-88. PubMed ID: 23368897
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler.
    Bodzenta-Lukaszyk A, Pulka G, Dymek A, Bumbacea D, McIver T, Schwab B, Mansikka H.
    Respir Med; 2011 May; 105(5):674-82. PubMed ID: 21196104
    [Abstract] [Full Text] [Related]

  • 24. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A.
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [Abstract] [Full Text] [Related]

  • 25. Fluticasone/formoterol: a new single-aerosol combination therapy for patients with asthma.
    Dissanayake S, Grothe B, Kaiser K.
    Respir Med; 2012 Dec; 106 Suppl 1():S20-8. PubMed ID: 23273163
    [Abstract] [Full Text] [Related]

  • 26. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?
    Vogelmeier C, D'Urzo A, Pauwels R, Merino JM, Jaspal M, Boutet S, Naya I, Price D.
    Eur Respir J; 2005 Nov; 26(5):819-28. PubMed ID: 16264042
    [Abstract] [Full Text] [Related]

  • 27. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K.
    Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
    [Abstract] [Full Text] [Related]

  • 28. Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma.
    Price D, Hillyer EV.
    Expert Rev Respir Med; 2014 Jun; 8(3):275-91. PubMed ID: 24802285
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial.
    Pertseva T, Dissanayake S, Kaiser K.
    Curr Med Res Opin; 2013 Oct; 29(10):1357-69. PubMed ID: 23865726
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 33. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct 29; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 34. Profiles of measured and perceived bronchodilation. A placebo-controlled cross-over trial comparing formoterol and salmeterol in moderate persistent asthma.
    Schermer TR, Hoff WJ, Greefhorst AP, Creemers JP, Sips AP, Westbroek J, van Herwaarden CL.
    Pulm Pharmacol Ther; 2004 Oct 29; 17(4):205-12. PubMed ID: 15219265
    [Abstract] [Full Text] [Related]

  • 35. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
    Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G.
    J Intern Med; 2013 Jun 29; 273(6):584-94. PubMed ID: 23495860
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 29; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 37. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct 29; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.
    Rabe KF, Timmer W, Sagkriotis A, Viel K.
    Chest; 2008 Aug 29; 134(2):255-262. PubMed ID: 18403672
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.